###begin article-title 0
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
The ITGAV rs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 65 71 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
###xml 178 184 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
###xml 278 284 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
The integrin alphavbeta3, whose alphav subunit is encoded by the ITGAV gene, plays a key role in angiogenesis. Hyperangiogenesis is involved in rheumatoid arthritis (RA) and the ITGAV gene is located in 2q31, one of the suggested RA susceptibility loci. Our aim was to test the ITGAV gene for association and linkage to RA in a family-based study from the European Caucasian population.
###end p 2
###begin p 3
###xml 148 155 <span type="species:ncbi:9606">patient</span>
Two single nucleotide polymorphisms were genotyped by PCR-restriction fragment length polymorphism in 100 French Caucasian RA trio families (one RA patient and both parents), 100 other French families and 265 European families available for replication. The genetic analyses for association and linkage were performed using the comparison of allelic frequencies (affected family-based controls), the transmission disequilibrium test, and the genotype relative risk.
###end p 3
###begin p 4
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 687 691 687 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
We observed a significant RA association for the C allele of rs3738919 in the first sample (affected family-based controls, RA index cases 66.5% versus controls 56.7%; P = 0.04). The second sample showed the same trend, and the third sample again showed a significant RA association. When all sets were combined, the association was confirmed (affected family-based controls, RA index cases 64.6% versus controls 58.1%; P = 0.005). The rs3738919-C allele was also linked to RA (transmission disequilibrium test, 56.5% versus50% of transmission; P = 0.009) and the C-allele-containing genotype was more frequent in RA index cases than in controls (RA index cases 372 versus controls 339; P = 0.002, odds ratio = 1.94, 95% confidence interval = 1.3-2.9).
###end p 4
###begin p 5
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
The rs3738919-C allele of the ITGAV gene is associated with RA in the European Caucasian population, suggesting ITGAV as a new minor RA susceptibility gene.
###end p 5
###begin p 6
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
See related editorial by Ahnert and Kirsten,  and related letter by Iikuni et al.,
###end p 6
###begin title 7
Introduction
###end title 7
###begin p 8
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 145 150 <span type="species:ncbi:9606">women</span>
Rheumatoid arthritis (RA) is the most common human systemic autoimmune disease (0.8% prevalence in the European Caucasian population), affecting women preferentially [1]. The disease is characterized by a chronic inflammation of the synovial tissues leading to the formation of the rheumatoid pannus, which erodes adjacent cartilage and bone, causing subsequent joint destruction. One hallmark of the pannus is hyperangiogenesis [2].
###end p 8
###begin p 9
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 292 301 292 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22 </italic>
###xml 313 314 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA </italic>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 535 541 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD51</italic>
###xml 559 565 559 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;v</italic>
###xml 1119 1120 1104 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1325 1326 1310 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
Previous studies have indicated that the risk of developing the disease in siblings of affected individuals is 2-17 times higher than in the general population, suggesting the importance of genetic factors [1]. Two RA genes have so far been established and confirmed using familial material, HLA-DRB1 and PTPN22 [3,4], but they account only for a part of the RA genetic component. The dense genome scan realized in our laboratory suggested 19 non-HLA regions in the French Caucasian population [5] and one of these, 2q31, contains the ITGAV gene (alias CD51, alphav), which encodes the alphav subunit of the integrin family. This family is composed of at least 24 heterodimeric combinations of 18 alpha subunits and nine beta subunits. These transmembranous receptors are expressed at the surface of numerous cells (endothelial cells, macrophages, monocytes, osteoclasts, platelets) and recognize the RGD sequence (Arg-Gly-Asp) of many ligands (such as vitronectin, fibronectin, osteopontin, sialoprotein, thrombospondin, fibrinogen, von Willebrand factor, tenascin, agrin, matrix metalloproteinases, and prothrombin) [6]. The integrins are involved in several functions including adhesion of activated endothelial cells with the extracellular matrix, proliferation, migration, and differentiation signals of vascular cells [6].
###end p 9
###begin p 10
###xml 88 94 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
###xml 126 135 119 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in utero </italic>
###xml 188 189 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 190 191 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
The alphavbeta3 integrin is well documented to play a key role in angiogenesis, and the ITGAV knockout animal model is lethal in utero for 80% with a presence of large vascular anomalies [7,8].
###end p 10
###begin p 11
###xml 326 327 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 468 469 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 470 472 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Angiogenesis also plays a key role in RA when the synovial membrane becomes hyperplasic and destroys the cartilage. We can observe an excess of blood cells (macrophages, T lymphocytes) in the synovial membrane and fluid, and some alphavbeta3 ligands (that is, fibrinogen or osteopontin) are abundant in the RA synovial fluid [7]. Moreover, some proangiogenic mediators (that is, vascular endothelial growth factor) are overexpressed in RA synovial membrane and serum [9,10].
###end p 11
###begin p 12
###xml 124 126 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 127 129 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 258 260 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
In addition, several alphavbeta3 antagonists and angiogenesis inhibitors have been successfully tested on RA animal models [11-14]. The alphavbeta3 integrin could therefore become a new therapeutic target in RA, and some clinical studies have already begun [15].
###end p 12
###begin p 13
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
Our aim was to use RA familial material to test two intronic ITGAV single nucleotide polymorphisms (SNPs) for RA association and linkage in the European Caucasian population.
###end p 13
###begin title 14
Materials and methods
###end title 14
###begin p 15
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 384 392 <span type="species:ncbi:9606">patients</span>
All subjects provided informed consent, and the ethics committee of Hopital Bicetre (Kremlin-Bicetre, Assistance Publique-Hopitaux de Paris, France) approved the study. RA families were recruited through a national media campaign followed by selection of individuals who fulfilled the 1987 American College of Rheumatology criteria for RA according to the physicians in charge of the patients [16]. A rheumatologist university fellow reviewed all clinical data.
###end p 15
###begin title 16
Sample 1
###end title 16
###begin p 17
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 356 365 356 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 97 104 <span type="species:ncbi:9606">patient</span>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
###xml 215 220 <span type="species:ncbi:9606">women</span>
###xml 281 289 <span type="species:ncbi:9606">patients</span>
###xml 326 334 <span type="species:ncbi:9606">patients</span>
###xml 494 502 <span type="species:ncbi:9606">patients</span>
Sample 1 (Table 1) constituted the DNA from 100 French Caucasian unrelated trio families (one RA patient and both parents) with the four grandparents of French Caucasian origin. Among these 100 RA patients, 87 were women; their mean age at disease onset was 32 years. In total, 81 patients were rheumatoid factor positive, 78 patients carried at least one HLA-DRB1 'shared epitope' susceptibility allele (DRB1*0101, DRB1*0102, DRB1*0401, DRB1*0404, DRB1*0405, DRB1*0408, DRB1*1001) [17] and 90 patients presented erosion.
###end p 17
###begin p 18
Characteristics of rheumatoid arthritis (RA) index cases from the investigated samples
###end p 18
###begin p 19
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
n, number of cases.
###end p 19
###begin title 20
Sample 2
###end title 20
###begin p 21
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 328 337 328 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 162 170 <span type="species:ncbi:9606">patients</span>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
###xml 189 194 <span type="species:ncbi:9606">women</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
###xml 359 367 <span type="species:ncbi:9606">patients</span>
Sample 2 (Table 1) was made up of the DNA from another 100 French Caucasian unrelated trio families with the same characteristics as sample 1. Among these 100 RA patients, 90 patients were women; their mean age at disease onset was 31 years. In all, 76 patients were rheumatoid factor positive, 80 patients carried at least one HLA-DRB1 shared epitope and 79 patients had an erosive disease.
###end p 21
###begin title 22
Sample 3
###end title 22
###begin p 23
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Sample 3 (Table 1) contained the DNA from 265 European Caucasian unrelated trio families with the same characteristics as sample 1, except for a shorter mean disease duration and a different ethnic origin (Caucasian families from France, Italy, Portugal, Spain, Belgium, and The Netherlands).
###end p 23
###begin title 24
Genotyping
###end title 24
###begin p 25
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
DNA was isolated and purified from whole blood according to standard protocols [18]. Two intronic SNPs were selected at the 5' and 3' ends of the gene with a minor allele frequency >25% for European population databases. Moreover the presence of a restriction site for one of the alleles was required (SNP1, rs3768777; SNP2, rs3738919 [19,20]). Genotyping was performed by the PCR followed by restriction fragment length polymorphism method [21].
###end p 25
###begin p 26
The designed primers were: sense, 5'-AAGTTGCCAACGTTCCGCGTTGCA-3' and antisense, 5'-GTAGTAGAAGATGGTCCTATCCACG-3' for SNP1; and sense, 5'-ATTTCCAGGTGGAACTTCTTTTGGA-3' and antisense, 5'-TCACAATTCAGATTTTTGCCACTGG-3' for SNP2.
###end p 26
###begin p 27
###xml 263 264 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 352 353 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
PCR amplification of SNP1 and SNP2 was performed on each sample in a 25 mul reaction volume consisting of 10 U PCR buffer (Perkin Elmer, Boston, MA, USA), 1.25 mM each dNTP, 1.25 U AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster City, CA, USA), 3 mM MgCl2, 0.0125 nM of the two primers and 50 ng genomic DNA, diluted to the final volume with H2O on an Eppendorf thermocycler using a hot start procedure. The PCR program was carried out using a first denaturation cycle of 94degreesC for 10 minutes followed by 37 cycles of denaturation at 94degreesC for 40 seconds, with an annealing temperature at 67degreesC for 30 seconds followed by an elongation step at 72degreesC for 1 minute. One final cycle of the extension was performed at 72degreesC for 2 minutes.
###end p 27
###begin p 28
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nla</italic>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
For SNP1, a 341-bp amplified fragment was digested with NlaIII, generating two fragments when the restriction site was present (A allele). For SNP2, the resulting 501-bp fragment was digested with AluI, generating three fragments for the C allele (126 bp, 161 bp and 214 bp), and two fragments for the A allele (permanent restriction site allowing one to validate the restriction protocol; 161 bp and 340 bp). Genotypes were assessed blindly by two independent investigators (LJ and CP). CEPH controls (1347-02 and 884-15) and 40 patients chosen at random were genotyped for quality control. All genotype data will be available online [22].
###end p 28
###begin title 29
Power calculation
###end title 29
###begin p 30
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 274 276 274 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
Using the European population minor allele frequency of 29% and 35% for SNP1 and SNP2, respectively, a sample size of 100 patients and 100 controls, and the arc sinus transformation method described by Garnier and colleagues [23], we had 80% power to detect an association (P < 0.05) if the difference in allelic frequencies between patients and controls was at least 11% for SNP1 and 12.2% for SNP2.
###end p 30
###begin title 31
Statistical analysis
###end title 31
###begin p 32
Prior to association tests, we checked the Hardy-Weinberg equilibrium in 'virtual controls' (constituted by parental untransmitted alleles to RA index cases).
###end p 32
###begin p 33
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 534 536 534 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 479 487 <span type="species:ncbi:9606">patients</span>
The association and linkage between each polymorphism and RA was examined by three different methods: the affected family-based controls (AFBAC) method was used to compare transmitted and untransmitted allelic frequencies across all families, the transmission disequilibrium test (TDT) was used to detect linkage through preferential transmission of one allele to the affected subjects, and the genotype relative risk (GRR) test was used to compare the genotypic distribution in patients and controls [24-26]. The significance of the P value was assessed at 5%, leading to replication tests in sample 2 and, in the case of relevant results, in the larger sample 3.
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
Hardy-Weinberg equilibrium
###end title 35
###begin p 36
Hardy-Weinberg equilibrium in the virtual controls was respected for SNP1 and SNP2 in sample 1 and in the replication samples (data not shown).
###end p 36
###begin title 37
Test for association and linkage in sample 1
###end title 37
###begin p 38
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 291 293 291 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
We observed neither significant association nor linkage between SNP1 and RA in sample 1. For SNP2, we observed a significant association for the C allele and a strong trend for a RA linkage (AFBAC, RA index cases 66.5% versus controls 56.7%, P = 0.04; TDT, 59.7% of transmission versus 50%, P = 0.06) (Table 2). The GRR test showed a significant increase of the C/C genotype and an excess of C-allele-containing genotypes in patients (Table 3).
###end p 38
###begin p 39
Affected family-based control and transmission disequilibrium test analyses for single nucleotide polymorphism (SNP)1 and SNP2 in sample 1 of rheumatoid arthritis trio families
###end p 39
###begin p 40
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
n, number of heterozygote parents.
###end p 40
###begin p 41
Genotype relative risk analysis for single nucleotide polymorphism (SNP)1 and SNP2 in sample 1 of rheumatoid arthritis trio families
###end p 41
###begin p 42
###xml 92 95 92 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D' </italic>
###xml 241 244 241 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GA </italic>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
The linkage disequilibrium test showed a weak linkage disequilibrium between SNP1 and SNP2 (D' = 0.33), and were thus considered independent. The results of the haplotypic TDT analysis showed a significant undertransmission of the SNP1/SNP2 GA haplotype (21 versus 37, P = 0.03), and a trend for an overtransmission of the two haplotypes containing the C allele of SNP2 (data not shown).
###end p 42
###begin p 43
###xml 84 96 84 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTPN22-620W </italic>
###xml 110 119 110 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA-DRB1 </italic>
###xml 173 179 173 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
When stratifying the sample for the families with the index presenting at least one PTPN22-620W allele or the HLA-DRB1 allele shared epitope status, no correlation with the ITGAV genotypes could be observed (data not shown).
###end p 43
###begin title 44
Test for association and linkage in sample 2
###end title 44
###begin p 45
The significant association observed for SNP2 in sample 1 led to a replication test in a second set of 100 French Caucasian Trio families (sample 2) on the hypothesis of an association of the C allele.
###end p 45
###begin p 46
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
In this sample, we observed a trend for association and linkage of the C allele with RA (AFBAC, RA index cases 63.1% versus controls 59.6%, P = 0.4; TDT, 52.6% of transmission, P = 0.6) (Table 4). The GRR test showed a trend for an excess of the C-allele-containing genotype in RA index cases compared with controls (90 RA index cases versus 79 controls, P = 0.09) but not for the C/C genotype (Table 5).
###end p 46
###begin p 47
Affected family-based control and transmission disequilibrium test analyses for single nucleotide polymorphism 2 in sample 2 of rheumatoid arthritis trio families
###end p 47
###begin p 48
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
n, number of heterozygote parents.
###end p 48
###begin p 49
Genotype relative risk analysis for single nucleotide polymorphism 2 in sample 2 of rheumatoid arthritis trio families
###end p 49
###begin p 50
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
The combination of the two samples, authorized by the absence of any significant clinical difference between them, showed a marginally significant association of the C allele (AFBAC, RA index cases 64.8% versus controls 58.2%, P = 0.05; TDT, 56.1% of transmission, P = 0.09) and a significant excess of the C-allele-containing genotype in RA index cases compared with controls (173 RA index cases versus 157 controls, P = 0.02).
###end p 50
###begin title 51
Test for association and linkage in sample 3
###end title 51
###begin p 52
###xml 328 330 328 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The trend for association of the C allele observed in sample 2 was in the same direction as the significant association observed in sample 1, without reaching statistical significance - notably due to a lack of power (the power to detect a significant association in sample 2, based on the allelic frequencies in sample 1, with P < 0.05, was only 51%). A larger replication test (265 families, sample 3) was therefore conducted on the hypothesis of an association of the C allele and of the C-allele-containing genotype.
###end p 52
###begin p 53
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 169 171 169 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 333 337 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T7">7</xref>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
We observed a significant RA association and linkage for the C allele (AFBAC, RA index cases 64.4% versus controls 57.8%, P = 0.03; TDT, 57% of transmission versus 50%, P = 0.04) (Table 6). This increase was supported by a significant increase of the C-allele-containing genotype in patients (199 RA index cases versus 182 controls, P = 0.02) (Table 7).
###end p 53
###begin p 54
Affected family-based control and transmission disequilibrium test analyses for single nucleotide polymorphism 2 in sample 3 of rheumatoid arthritis trio families
###end p 54
###begin p 55
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
n, number of heterozygote parents.
###end p 55
###begin p 56
Genotype relative risk analysis for single nucleotide polymorphism 2 in sample 3 of rheumatoid arthritis trio families
###end p 56
###begin title 57
Test for association and linkage in the combined samples 1 + 2 + 3
###end title 57
###begin p 58
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T8">8</xref>
###xml 374 378 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T9">9</xref>
###xml 324 332 <span type="species:ncbi:9606">patients</span>
The combination of the three samples, authorized by the absence of a significant clinical difference between them, confirmed association and linkage for the C allele (AFBAC, 64.6% versus 58.1%, P = 0.005; TDT, 56.5% of transmission, P = 0.009) (Table 8). The GRR test showed an excess of the C-allele-containing genotype in patients (372 RA index cases versus 339 controls, P = 0.002, odds ratio = 1.94, 95% confidence interval = 1.3-2.9) (Table 9).
###end p 58
###begin p 59
Affected family-based control and transmission disequilibrium test analyses for single nucleotide polymorphism 2 in the combined samples 1 + 2 + 3
###end p 59
###begin p 60
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
n, number of heterozygote parents.
###end p 60
###begin p 61
Genotype relative risk analysis for single nucleotide polymorphism 2 in the combined samples 1 + 2 + 3
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HLA </italic>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
We studied the ITGAV gene, a good RA candidate gene for its function implicated in angiogenesis, and its chromosomal location (in one of the 19 suggested non-HLA loci of our dense genome scan) [5]. We observed a significant RA association for the C allele of rs3738919 in a first sample of French Caucasian families, the same trend in replication sample 2, and again a significant association in replication sample 3 (European Caucasian families). Finally, significant RA association and linkage were observed when all sets were combined.
###end p 63
###begin p 64
###xml 274 292 274 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV rs3738919-C </italic>
###xml 465 467 465 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 355 363 <span type="species:ncbi:9606">patients</span>
The association and linkage evidences provided by the present study remain nevertheless statistically modest, suggesting at most a minor RA susceptibility marker. Further studies in independent samples will be needed to definitively establish association and linkage of the ITGAV rs3738919-C allele to RA. For the observed allelic frequencies of 64.6% in patients versus 58.1% in controls, a sample size of 350 families would be required to obtain, with 80% power (P < 0.05), an independent replication of the association evidence reported here.
###end p 64
###begin p 65
Once this association had been replicated, resequencing would be necessary to identify exonic and promoter SNPs to refine the associated haplotype.
###end p 65
###begin p 66
###xml 153 159 153 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
In the same way, the chromosome 2 linkage suggestion observed in the genome scan of our laboratory could not be totally explained by the findings of the ITGAV linkage; hence, with the overtransmission observed in the TDT, the allele sharing expected for the affected sib-pair siblings would be about 53% and would necessitate thousands of sibling pairs to be revealed. Other RA genes in this chromosomal location and/or epistatic effects could be expected to be stronger RA factors that remain to be discovered.
###end p 66
###begin p 67
Since the association evidence is modest, no genetic testing would be clinically indicated. Instead, the clinical relevance of the finding is likely to come through better understanding of the RA pathophysiology and may lead to new therapeutic targets.
###end p 67
###begin p 68
###xml 94 112 94 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV rs3738919-C </italic>
Contrary to the result of the GRR test in sample 1, which suggested a recessive effect of the ITGAV rs3738919-C allele, the result of the larger combined sample is more in favour of a dominant effect of this marker. This difference could be explained by the relatively small size of the first sample.
###end p 68
###begin p 69
###xml 138 156 138 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV rs3738919-C </italic>
Finally, regarding the key function of angiogenesis in others diseases, and in particular in cancers, it would be interesting to test the ITGAV rs3738919-C allele in these phenotypes.
###end p 69
###begin title 70
Conclusion
###end title 70
###begin p 71
###xml 71 83 71 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rs3738919-C </italic>
###xml 97 103 97 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITGAV </italic>
The present study showed a significant association and linkage for the rs3738919-C allele of the ITGAV gene with RA in the European Caucasian population, suggesting ITGAV as a new minor RA susceptibility gene in this population.
###end p 71
###begin title 72
Abbreviations
###end title 72
###begin p 73
AFBAC = affected family-based controls; bp = base pair; GRR = genotype relative risk; PCR = polymerase chain reaction; RA = rheumatoid arthritis; SNP = single nucleotide polymorphism; TDT = transmission disequilibrium test.
###end p 73
###begin title 74
Competing interests
###end title 74
###begin p 75
The authors declare that they have no competing interests.
###end p 75
###begin title 76
Authors' contributions
###end title 76
###begin p 77
LJ, CP, EG and SG carried out the molecular genetic studies. LJ, CP, SBa, SG, PD, LM, HM, VHT, BP, EP-T and FC performed acquisition and analysis of the data. LM, SL, IL, PQ, PH, PM, AB, RW, PB, HA, CV, MF, DP-S, SBo, JD, TRR, PVR, LvdP, AL-V, TB, and the European Consortium on Rheumatoid Arthritis Families contributed to the recruitment of families and to the acquisition of clinical data. All authors read and approved the final manuscript.
###end p 77
###begin title 78
Acknowledgements
###end title 78
###begin p 79
The authors thank the RA members and their rheumatologists for their participation. This work was funded by the Association Francaise des Polyarthritiques, the Association de Recherche pour la Polyarthrite, the Association Polyarctique, the Association Rhumatisme et Travail, the Societe Francaise de Rhumatologie, Genopole, the Universite d'Evry-Val d'Essonne, Shering-Plough, Pfizer, Amgen, the Conseil Regional Ile de France, the Conseil General de l' Essonne, the Ministere de la Recherche et de l'Enseignement Superieur, the Fondation pour la Recherche Medicale, and the Centre Hospitalier Sud Francilien (France). VHT's work was supported by the Foundation for Sciences and Technology, Portugal (Grant SFRH/BD/23304/2005).
###end p 79
###begin p 80
###xml 286 291 <span type="species:ncbi:66662">Balsa</span>
The European Consortium on Rheumatoid Arthritis Families was initiated with funding from the European Commission (BIOMED2) by: T Bardin, D Charron, F Cornelis (coordinator), S Faure, D Kuntz, M Martinez, JF Prudhomme and J Weissenbach (France); R Westhovens and J Dequeker (Belgium); A Balsa and D Pascual-Salcedo (Spain); M Spyropoulou and C Stavropoulos (Greece); P Migliorini and S Bombardieri (Italy); P Barrera and L Van de Putte (Netherlands); andH Alves and A Lopes-Vaz (Portugal). This work was in part funded by AutoCure European Funding.
###end p 80
###begin article-title 81
The genetics revolution and the assault on rheumatoid arthritis
###end article-title 81
###begin article-title 82
Rheumatoid arthritis
###end article-title 82
###begin article-title 83
Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele
###end article-title 83
###begin article-title 84
Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis
###end article-title 84
###begin article-title 85
Dense genome-wide linkage analysis of rheumatoid arthritis including covariates
###end article-title 85
###begin article-title 86
The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical developments
###end article-title 86
###begin article-title 87
Definition of two angiogenic pathways by distinct alpha v integrins
###end article-title 87
###begin article-title 88
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins
###end article-title 88
###begin article-title 89
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis
###end article-title 89
###begin article-title 90
###xml 43 48 <span type="species:ncbi:9606">human</span>
Hypoxic-reperfusion injury in the inflamed human joint
###end article-title 90
###begin article-title 91
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis
###end article-title 91
###begin article-title 92
###xml 48 55 <span type="species:ncbi:9986">rabbits</span>
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist
###end article-title 92
###begin article-title 93
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature
###end article-title 93
###begin article-title 94
###xml 115 118 <span type="species:ncbi:10116">rat</span>
Disease-modifying activity of SB 27 an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis
###end article-title 94
###begin article-title 95
Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases
###end article-title 95
###begin article-title 96
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
###end article-title 96
###begin article-title 97
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
###end article-title 97
###begin article-title 98
National Center for Biotechnology Information
###end article-title 98
###begin article-title 99
The Bio-web
###end article-title 99
###begin article-title 100
###xml 41 44 <span type="species:ncbi:9606">man</span>
Construction of a genetic linkage map in man using restriction fragment length polymorphisms
###end article-title 100
###begin article-title 101
Genhotel EA-3886
###end article-title 101
###begin article-title 102
IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis
###end article-title 102
###begin article-title 103
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM)
###end article-title 103
###begin article-title 104
Mapping disease genes: family-based association studies
###end article-title 104
###begin article-title 105
Estimating genotype relative risks
###end article-title 105

